Trial NCT05134194

View at ClinicalTrials.gov 
Org. Study IDs: SHR-1210-III-327

Last trial update was posted on 2024-04-16

MeSH Interventions

Capecitabine Gemcitabine Vinorelbine

MeSH Conditions

Breast Neoplasms Triple Negative Breast Neoplasms

Other Conditions

Triple Negative Breast Cancer

Stopping Reasons

Sponsor R & D Strategy Adjustment]

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID